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Abstract 
 
The objective of this study was to explore the interaction between mouse C2C12 
cells and the extracellular matrix, particularly the process of myoblasts converting 
to myocytes.  This study aimed to create a myogenesis assay that presents a 
process to effectively monitor the development of mouse C2C12 myoblasts into 
differentiated skeletal myotubes through detection of the protein MyoD.  
Myogenesis, the development of muscle tissue, occurs when muscle progenitor 
cells, myoblasts, fuse to form multinucleated myotubes, followed by cell fusion 
and resulting in a myofiber capable of contraction.  An in vitro myogenesis assay 
would enable further research to efficiently test the effect of various growth 
factors and other parameters on skeletal muscle development, a field with 
numerous clinical applications. To test this, cells were seeded on both control 
substrates and wells coated with extracellular matrix. Cells were harvested at 3 
and 7 days and tested for presence of MyoD. Analysis of PCR results showed 
negligible amounts of MyoD present in all experimental wells. 
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Introduction 
Volumetric muscle loss can be defined as the loss of skeletal muscle resulting in 
a reduction or total loss of functionality2.  Volumetric muscle loss is a common 
injury in the military, as improvised explosive devices have been used 
extensively in recent wars.  Resulting soft tissue injuries and treatment of 
compartment syndrome in the extremities have left many veterans with loss of 
muscle functionality14.  Volumetric muscle loss is also common in civilian life, as 
it can be caused by injuries such as vehicle accidents, gunshot wounds, and 
surgical excisions.   
 
The replacement of tissue and promotion of muscle repair following volumetric 
muscle loss is a prominent challenge currently being investigated in tissue 
engineering.  Lack of donor tissue limits the efficacy of procedures using muscle 
grafts to replace volumetric muscle loss, and the added challenge of donor-site 
morbidity has caused physicians and scientists to turn to tissue engineering as 
the most promising alternative to current free muscle transplant procedures10.  
Tissue engineering, as a field, seeks to either replace or improve biological 
tissues through the combined use of engineered materials, cells, and 
biochemical growth factors.  Muscle tissue engineering is the branch of tissue 
engineering that focuses on the replacement of muscle tissue.   
 
The process of muscular tissue formation is known as myogenesis.  In order to 
understand adult myogenesis in fully developed skeletal muscle, it is necessary 
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to first understand embryonic myogenesis.  As the body develops, satellite cells 
differentiate into embryonic myoblasts that divide rapidly in the presence of 
fibroblast growth factor.  Following myoblast proliferation, myoblasts commit to 
differentiation, align and join to create myotubes, which are multi-nucleated 
fibers. Myotubes then mature into fully mature and functional skeletal muscle 
units known as myofibers1.  This process is illustrated in Figure 1. 
 
 
Figure 1. Illustration of myogenesis, the path from a satellite cell to a mature 
myofiber15 
 
Various genetic factors are associated with the different stages of myogenesis, 
both adult and embryonic.  For example, the myogenic regulatory factor family of 
basic helix loop helix transcription factors play a large role in the process of 
myogenesis, as they both activate the formation of muscle fibers and directly 
regulate muscle gene transcription8.  MyoD, a protein in the myogenic regulatory 
factor family, is necessary for both the initial conversion of a satellite cell to a 
skeletal myoblast and for regulation of the myoblast throughout myogenesis. 
MyoD self-activates transcription, inducing its characteristic stability in 
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commitment to myogenesis and its role in differentiation and repair of injured 
skeletal muscle13.  
 
The adult human body is capable of muscle regeneration, but only to a certain 
extent3.  Necrosis, or death, of muscle cells signals muscle tissue to begin the 
process of biological repair and muscle tissue regeneration.  Muscle regeneration 
is a challenging process, as new muscle must contain vasculature sufficient to 
supply the new tissue with oxygen and innervation sufficient for the recovery of 
muscle functionality. Skeletal muscle, in comparison to cardiac and smooth 
muscle, is capable of a relatively large amount of regeneration due to cells 
known as myosatellite cells3.  
 
Myosatellite cells, as with all human skeletal muscle cells, develop embryonically 
from the paraxial mesoderm, specifically the somites.  Throughout development, 
they become part of the dermomyotome7.  After the embryonic dermomyotome 
differentiation of primary muscle fibers, populations expressing transcription 
factors for myosatellite cells exist within the fetal skeletal muscle until a period 
late in the development of the fetus, at which time the myosatellite cells are 
produced7.  The signaling pathway throughout this fetal development of 
myosatellite cells is not well understood and is under investigation by several 
groups9,12.   
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In a fully developed adult, myosatellite cells are quiescent and are found between 
the basal lamina and the sarcolemma of the muscle fibers with which they are 
associated4.  The quiescent state persists until the myosatellites receive an 
activation signal indicative of injury to muscle tissue.  This signal is transmitted 
from the plasma membrane via sphingosine-1-phosphate, a signaling 
sphingolipid that incites the myosatellite cell to enter the cell cycle.  Mechanical 
factors such as stretch can also lead to the activation of myosatellite cells via the 
release of myogenesis stimulants such as hepatocyte growth factor or Follistatin, 
a molecule that inhibits the negative regulation of myogenesis caused by 
Myostatin7.  Yet another mode of myosatellite cell activation is that of growth 
factors secreted by the microenvironment.  Specifically, fibroblast growth factors 
have been shown to trigger MAPK signal cascades, which are prerequisite to 
myosatellite cell activation5.  
 
Upon activation by muscle injury, myosatellite cells travel to existing muscle 
fibers, which they will adhere to in effort to repair damaged fibers and form new 
fibers.  Activated myosatellite cells proliferate rapidly and differentiate into 
myoblasts, at which stage they divide several times prior to forming 
multinucleated myofibers7.  Due to the terminally differentiated nature of existing 
muscle fibers present in adult skeletal muscle, myosatellite cells are solely 
responsible for muscle regeneration following injury.  
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Volumetric muscle loss describes damage to skeletal muscle that results in the 
loss of more tissue than the body is capable of regenerating on its own2.  As 
muscle tissue engineering seeks to solve this problem through creation of 
artificial muscle and promotion of muscle regeneration, it is necessary to further 
understand the effects of growth factors and other biochemical substances on 
myogenesis.  Exclusive use of animal models presents challenges with regard to 
both time and cost, which leads to the need for an in vitro assay for use in 
preliminary testing.   
 
As stated previously, MyoD is a protein of the myogenic regulatory factor family 
that serves as a marker of myoblast commitment to myogenesis13. When 
investigating potential tissue engineering methods for promotion of muscle 
regeneration, it is possible to use MyoD as a screening tool.  An increased 
concentration of MyoD indicates greater myoblast commitment to myogenesis, 
and thus greater muscle regeneration.  This study aimed to profile the expression 
of MyoD to create an in vitro myogenesis assay for use in the development of 
muscle regeneration therapies. 
 
Methods 
In order to test for adequate profiling of MyoD expression in an in vitro assay 
while simultaneously investigating the effect of extracellular matrix (ECM) on 
C2C12 mouse myoblast cells, six different experimental parameters were tested.  
Cells were seeded on a control substrate, a substrate coated with 1 mg ECM per 
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mL water, and a substrate coated with 10 mg ECM per mL water to investigate 
the effect of the ECM on myoblast differentiation.  Cells were collected at 3 and 7 
days for each of the substrate conditions.  All experimental cells underwent RNA 
purification, reverse transcription, and polymerase chain reaction to test for 
presence of MyoD. 
 
Muscle harvest 
Following the sacrifice of mature Sprague-Dawley rats, all tibialis anterior, bicep 
femoris, and gastrocnemius muscles were harvested and rinsed in deionized 
water to remove hair and debris.  Muscle tissue was then stored in scintillation 
vials and frozen at -20°C until enough tissue was harvested to proceed to 
decellularization. 
 
Muscle decellularization 
All muscle tissues were removed from -20°C and submerged in a room 
temperature solution of 1% sodium dodecyl sulfate (Amresco) in 1X pH 7.4 
phosphate buffered saline (Life Technologies).  The scintillation vials were sealed 
and left on a rocking plate.  The solution was replaced every 24 hours until the 
solution became colorless.  The length of this process was approximately 4 days.  
Muscle tissues were then submerged in deionized water, which was exchanged 
every 6 hours for 24 hours.  Muscle tissue was left submerged overnight in a 1X 
pH 7.4 phosphate buffered saline solution.  The following day, the muscle was 
rinsed 3 times in deionized water and left in water overnight.  At this point, the 
	   10	  
muscle was completely decellularized and all that remained was the ECM.  The 
difference in original and decellularized muscle is shown in Figure 2. 
 
  
Figure 2. Rat bicep femoris before (left) and after (right) decellularization using 
1% sodium dodecyl sulfate in 1X phosphate buffered saline solution 
 
Preparation of ECM 
ECM was then ground into a fine powder using a mortar and pestle.  One piece 
of decellularized muscle tissue at a time was placed into the mortar, after which 
liquid nitrogen was poured over the tissue.  The pestle was then used to powder 
the tissue, after which the powder was added to a clean scintillation vial.  ECM 
powder was stored at 4°C until later use. 
 
Preparation of 12-well plate 
To test the effect of ECM on cell growth, 3 different powder concentrations were 
used to coat the bottom of two 12-well plates (Greiner Bio-One).  1 mL of pure 
deionized water was added to 8 wells, 1 mL of 1mg ECM/mL deionized water 
was added to 8 wells, and 1 mL of 10 mg ECM/mL deionized water was added to 
8 wells.  All water was then allowed to evaporate overnight with the lids of the 12-
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well plate turned slightly askew inside a running biosafety cabinet.  Both 12-well 
plates were then sterilized using a traditional ethylene oxide sterilization cycle.  
Note: an additional 12-well plate with no water or ECM powder was also 
prepared and later seeded with cells purely for post-experiment cell density 
imaging purposes. 
 
Figure 3. Well of 10 mg ECM powder per mL deionized water, post-evaporation 
of 1 mL solution 
 
 
Preparation of C2C12 cells 
C2C12 mouse myoblast cells (ATCC) were used in all cultures.  Culture medium 
consisted of Gibco Dulbecco’s Modified Eagle Medium (DMEMF12) with 10% 
Gibco Fetal Bovine Serum, 1% Gibco GlutaMax L-Glutamine, and 0.1% Gibco 
Gentamicin reagent solution.  12 mL of culture media and one thawed vial of 
C2C12 cells were added to a T-75 flask (Greiner Bio-One) and incubated at 
37°C.  Media was replaced every 48 hours until cells reached 75% confluence, at 
which point cells were expanded to prevent premature differentiation.  At 75% 
confluence, cells were passaged and split to two T-175 flasks.  The 75% 
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confluent cells were treated with 0.25% trypsin-EDTA for detachment.  Upon 
detachment, cells were removed from T-75 flask and centrifuged 5 minutes at 
300G.  Following centrifugation, supernatant was removed and 10 mL of new 
media was added to the cells.  The cell pellet was broken up by pipetting the new 
media several times.  5 mL of evenly distributed cell and media mixture was 
added to each of the new T-175 flasks.  An additional 12 mL of new media was 
added to each flask.  Cells were allowed to reach 75% confluence, with media 
being exchanged every 48 hours. 
 
Seeding Cells 
Aiming to seed all C2C12 cells at 30% confluence, a concentration of 14,400 
cells/cm2 (55,000 cells/well) was utilized for all wells in 12-well plate.  A total of 24 
experimental wells and 4 imaging wells were seeded at 30% confluence and 
media was added for a total volume of 1 mL/well.  Previously described 
detachment techniques were used.  55,000 cells/well were also added to 4 
additional wells, to be used solely for post-experiment cell density imaging. 
 
Collecting Cells 
72 hours after seeding cells, 4 wells of each ECM powder concentration sample 
group (0 mg/mL, 1 mg/mL, 10 mg/mL) were collected.  After media was removed 
from these 12 wells, 200 uL new media and 1 mL RNAprotect cell reagent 
(Qiagen) were added to each well and incubated at 37°C for 15 minutes.  
Following incubation, cells were fully detached.  The contents of each of the 12 
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wells were transferred to a separate labeled 1.5 mL microcentrifuge tube 
(Qiagen) and stored at -80°C.  Media was removed from 2 of the 4 wells seeded 
for imaging and 1 mL 4% paraformaldehyde (Sigma) was applied for 15 minutes 
to fix the cells.  Paraformaldehyde was removed and the cells were left 
submerged in 1X pH 7.4 phosphate buffered saline at 4°C, where they were left 
until imaging.  Used media was removed and 1mL new media was applied to the 
12 experimental and 2 imaging wells that were not either fixed or detached. 
 
7 days after the seeding of cells, the remaining 4 wells of each ECM powder 
concentration sample group were collected.  After media was removed from 
these 12 wells, 200 uL new media and 1 mL RNAprotect cell reagent (Qiagen) 
were added to each well and incubated at 37°C for 15 minutes.  Following 
incubation, cells were fully detached.  The contents of each of the 12 wells was 
transferred to a separate labeled 1.5 mL microcentrifuge tube (Qiagen) and 
stored at -80°C.  Media was removed from the remaining 2 wells seeded for 
imaging and and 1 mL 4% paraformaldehyde (Sigma) was applied for 15 minutes 
to fix the cells.  Paraformaldehyde was removed and the cells were left 
submerged in 1X pH 7.4 phosphate buffered saline at 4°C until imaging. 
  
Cell density imaging 
The 4 wells fixed for imaging were removed from 4°C and placed at room 
temperature.  Phosphate buffered saline was removed.  700 uL DAPI nucleic 
acid stain was added to each well and left for 10 minutes.  DAPI was then 
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removed and wells were rinsed 3 times with 1X pH 7.4 phosphate buffered 
saline.  Wells were then imaged at 100X. 
  
RNA purification and reverse transcription 
All RNA purification was performed using the RNeasy Protect Cell Mini Kit from 
Qiagen.  Following immediate stabilization of nucleic acids in experimental 
C2C12 cells using RNAprotect cell reagent as described above in the ‘collecting 
cells’ section, total RNA purification was performed.  Stabilized experimental cells 
were removed from storage at -80°C and allowed to thaw in a water bath at 
37°C.  After thawing, the cells were centrifuged.  The cell pellet was lysed and 
homogenized using a guanidine-thiocyanate buffer, thus inactivating RNAses to 
protect all existing RNA.  The homogenized lysate was placed in a gDNA 
Eliminator spin column, which used in conjunction with a salt buffer resulted in 
removal of all genomic DNA.  Ethanol was then added to RNA flow-through to 
allow RNA to bind, after which an RNeasy spin column was used to isolate RNA 
and eliminate all contaminants.  RNA was then eluted in RNAse-free water.  
Reverse transcription of isolated RNA was then performed using the iScript 
cDNA Synthesis Kit (Bio-Rad).  
 
Polymerase Chain Reaction 
All polymerase chain reaction (PCR) procedures were carried out using MyoD1 
primer (Bio-Rad) as a gene of interest, GAPDH primer (Bio-Rad) as a 
housekeeping gene, and SYBR Green (Bio-Rad) as a DNA-binding dye.  
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Results 
Cell density imaging results are shown in Figure 4.  There was a drastic increase 
in confluence of mouse C2C12 cells from 3 days to 7 days.  Cells were initially 
seeded at 30% confluence, and imaged with DAPI for nucleic acid staining.  All 
images were taken at 100X magnification. 
 
Figure 4. Mouse C2C12 cells at 3 (left) and 7 (right) days following seeding at 
30% confluence, imaged with DAPI for nucleic acid staining at 100X 
magnification 
  
Analysis of PCR results showed negligible amounts of MyoD present in all 
experimental wells. The housekeeping gene, GAPDH, presented at 2000-2500 
relative fluorescent units (RFU). PCR results showed there was no MyoD present 
in 11 of the 12 tested wells. The one well that contained MyoD presented at 1200 
RFU. 
 
Conclusion 
Results from PCR showed a lack of MyoD in 11 of 12 experimental wells.  The 
presence of GAPDH, the housekeeping gene, shows that there was indeed 
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enough genetic material collected and purified to glean results with PCR.  The 
absence of MyoD could possibly be due to presence of Myf5 instead, a similar 
gene with functional redundancy6.  The absence of MyoD also could indicate that 
the mouse C2C12 cells did not reach the confluence during the 3 to 7 days of 
incubation that was required for further differentiation and thus expression of 
MyoD.  
 
Results showing no MyoD in any experimental wells present the possibility that 
the model used in this experiment was ineffective.  Sources of error leading to an 
ineffective assay include but are not limited to media formulation and cell density.  
In a similar experiment by Kong et al., C2C12 myoblasts were treated with 
chloroquine and DNA calcium phosphate precipitates prior to plating in order to 
promote stable DNA transfections6.  Cells were also switched to a differentiation 
medium consisting of low-glucose DMEM and 2% horse serum prior to 
differentiation6.  Kong et al. used a similar seeding density to this experiment, 
differing by less than 1,000 cells/cm2, and allowed cultures a maximum of four 
days before harvest. 
 
Several operational shortcomings also arose throughout the experiment, 
including but not limited to RNA purification and PCR techniques.  Due to the 
inherent instability of RNA, storage at -80°C for several days prior to RNA 
purification could have affected the amount of RNA that was intact and available 
for isolation.  During RNA isolation, trace amounts of phenol could have 
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remained in the RNA, thus introducing error into RNA quantification.  
Degradation of the DNA template from nucleases in the testing environment or 
contaminants present in the master mix could have contributed to downstream 
error in PCR.  
 
Failure to detect MyoD effectively using this assay leads to a search for other 
methods of monitoring myogenesis.  In future work, another method of screening 
for myogenesis using an in vitro system could be utilization of imaging devices to 
monitor myoblast differentiation.  As myoblasts proliferate and differentiate, they 
align into a network of parallel, multinucleated myotubes7.  Through 
characterization of the surface topography of experimental wells, it is possible to 
quantify the degree of alignment and thus the degree of differentiation of 
myoblasts into myotubes. 
 
Future experimentation using RNA purification and PCR would call for further 
investigation into media formulations and protocols to promote myogenesis and 
appropriate cell culture length.  Significant presence of MyoD in similar studies 
was only noted after the use of specific differentiation mediums6. In future work, 
there is also need for additional practice in RNA isolation and PCR techniques in 
order to reduce the likelihood of DNA degradation, contamination, and pipette 
error. 
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